Healthcare & Life Sciences News and Articles

Google News – FDA (biotech/pharma) External News

FDA takes another look at botanical drugs - STAT

news.google.com · 04 Sep 2026

Google News – Biopharma External News

Regulatory Expectations Are Changing: 5 Issues Biopharma Leaders Are Grappling With in 2026 - BioBuzz

news.google.com · 04 Sep 2026

Google News – FDA (biotech/pharma) External News

Fierce Pharma Asia—Roche, GSK, Novartis billion-dollar deals; More MFN sign-ups; Akeso’s OS win - Fierce Pharma

news.google.com · 04 Sep 2026

Google News – Pharmaceuticals External News

A potentially blinding eye disease has no FDA-approved therapy. Tarsus bought a company developing one. - Stock Titan

news.google.com · 04 Sep 2026

Google News – Clinical Trials External News

Executive Director's speech at Duke-NUS Medical School in Singapore - European Medicines Agency (EMA)

news.google.com · 04 Sep 2026

Google News – Clinical Trials External News

Sensorion secures approval for HearConnex Phase I/II study in France - Clinical Trials Arena

news.google.com · 04 Sep 2026

Google News – Pharmaceuticals External News

Takeda Pharmaceutical (TSE:4502) Wins MIMRYLO Approval, Is The Stock Still Trading At A Discount? - simplywall.st

news.google.com · 04 Sep 2026

Google News – FDA (biotech/pharma) External News

FDA Contamination Warning Could Be A Game Changer For Jabil’s (JBL) Pharma Ambitions - simplywall.st

news.google.com · 04 Sep 2026

Google News – Pharmaceuticals External News

Does Japan’s First Pediatric ORLADEYO Approval Reshape The Bull Case For BioCryst Pharmaceuticals (BCRX)? - simplywall.st

news.google.com · 04 Sep 2026

Google News – Medical Devices External News

CBIC Issues Mandatory Compliance Checklists for Faster Customs Clearance of Cosmetics, Drugs and Medical Devices - A2Z Taxcorp LLP

news.google.com · 04 Sep 2026

Google News – Pharmaceuticals External News

Is Vertex Pharmaceuticals (VRTX) Undervalued Following Casgevy’s FDA Label Expansion? - simplywall.st

news.google.com · 04 Sep 2026

Industry News External News

US investment firm KKR buys stake in Malaysia's Avisena Healthcare - theedgemalaysia.com

news.google.com · 04 Sep 2026

Google News – Pharmaceuticals External News

Ionis Pharmaceuticals (IONS) Gains First-Mover Advantage with FDA Approval of Rare Brain Disease Drug - Yahoo Finance

news.google.com · 04 Sep 2026

Google News – FDA (biotech/pharma) External News

Ionis Pharma’s drug becomes first FDA-approved treatment for rare brain disorder - KELO-AM

news.google.com · 04 Sep 2026

Google News – FDA (biotech/pharma) External News

Ionis Pharma's drug becomes first FDA-approved treatment for rare brain disorder - KSL.com

news.google.com · 04 Sep 2026

News & Articles

From Roster to Resilience: Building a Workforce Risk Register

The Protocol-to-Workflow Specialist: A Career Emerging in Clinical Research

Build the Bench: Internal Mobility for Healthcare’s Hard-to-Fill Work

The Access Architect: A New Clinical Research Workforce Priority

Jury should decide if university’s hiring process was tainted by diversity goals, court rules

Running costs of vaccine damage scheme more than double amount paid to victims

CMS expands TAVR Medicare coverage to asymptomatic patients

Stryker stock falls on slower peripheral vascular, hip sales

Veterans Affairs taps Amwell for telehealth revamp - Healthcare Dive

8 stories on the healthcare affordability crunch

For women in the workforce, can AI be the ‘great equalizer’?

What building fair hiring under real regulation taught us, and why the U.S. is next

Inside L’Oréal’s hiring strategy behind 2 million applications a year

Campaigners hold vigil as stroke unit closes

Epidural Kit Correction: Medical Action Industries Issues Correction for Epidural Kits Containing Spectra Medical Devices Lidocaine Ampules

UK needs new laws for AI in healthcare, says watchdog

Migraines and acne among five more conditions pharmacists can treat

Maternal Mental Health Policy

4 questions about the FDA’s approach to generative AI

Presidential dialogue on high-threat pathogens

FDA takes another look at botanical drugs - STAT

Regulatory Expectations Are Changing: 5 Issues Biopharma Leaders Are Grappling With in 2026 - BioBuzz

Fierce Pharma Asia—Roche, GSK, Novartis billion-dollar deals; More MFN sign-ups; Akeso’s OS win - Fierce Pharma

A potentially blinding eye disease has no FDA-approved therapy. Tarsus bought a company developing one. - Stock Titan

Executive Director's speech at Duke-NUS Medical School in Singapore - European Medicines Agency (EMA)

Sensorion secures approval for HearConnex Phase I/II study in France - Clinical Trials Arena

Takeda Pharmaceutical (TSE:4502) Wins MIMRYLO Approval, Is The Stock Still Trading At A Discount? - simplywall.st

FDA Contamination Warning Could Be A Game Changer For Jabil’s (JBL) Pharma Ambitions - simplywall.st

Does Japan’s First Pediatric ORLADEYO Approval Reshape The Bull Case For BioCryst Pharmaceuticals (BCRX)? - simplywall.st

CBIC Issues Mandatory Compliance Checklists for Faster Customs Clearance of Cosmetics, Drugs and Medical Devices - A2Z Taxcorp LLP

Is Vertex Pharmaceuticals (VRTX) Undervalued Following Casgevy’s FDA Label Expansion? - simplywall.st

US investment firm KKR buys stake in Malaysia's Avisena Healthcare - theedgemalaysia.com

Ionis Pharmaceuticals (IONS) Gains First-Mover Advantage with FDA Approval of Rare Brain Disease Drug - Yahoo Finance

Ionis Pharma’s drug becomes first FDA-approved treatment for rare brain disorder - KELO-AM

Ionis Pharma's drug becomes first FDA-approved treatment for rare brain disorder - KSL.com